However, at the same time, UCP2 inhibits insulin secretion, which is manifested as an elevated content of ucp2 mRNA in rats with alloxan-induced diabetes vs. the diabetic group treated with SkQ1 (Figure 4). Here, INS is linked to diabetes mellitus.